Halozyme Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
04.12.25
/
50%
€53.66
Target price
04.12.26
€48.01
Performance (%)
22.59%
Price
12:46
€65.78
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr currently has a performance of 22.59%. This prediction currently runs until 04.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 10.822% | 10.822% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $56.00 price target on the stock.
Ratings data for HALO provided by MarketBeat